AEON Biopharma (AEON)

• Market cap: $9.9M
• 1 day: 0.71%
• 5 days: -10.38%
• 1 month: 5.12%
• 3 months: 16.87%
• 6 months: 96.3%
• Year to date: -97.85%
• 1 year: -98.71%
• 5 years: -99.88%
• 10 years: -99.88%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5